Interleukin-1 beta-induced nitric oxide production from isolated rat islets is modulated by D-glucose and 3-isobutyl-1-methyl xanthine

被引:37
作者
Andersen, HU
Mauricio, D
Karlsen, AE
MandrupPoulsen, T
Nielsen, JH
Nerup, J
机构
[1] STENO DIABET CTR,DK-2820 GENTOFTE,DENMARK
[2] HAGEDORN RES INST,DK-2820 GENTOFTE,DENMARK
关键词
D O I
10.1530/eje.0.1340251
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interleukin-1 beta has been proposed to cause selective beta-cell destruction via the induction of nitric oxide synthesis. The cytotoxic effect of interleukin-1 beta is modulated by the concentration of D-glucose in the medium. The aim of this study was to investigate if D-glucose-mediated modulation of interleukin-1 beta effects on insulin release from isolated rat islets was related to modulation of nitric oxide production. Further, we wished to investigate the effects of agents increasing the intracellular concentration of cAMP on interleukin-1 beta-induced nitrite production, We demonstrated that D-glucose potentiated interleukin-1 beta-induced nitrite production in rat islets without affecting the mRNA level of the inducible nitric oxide synthase. This effect was dissociated from interleukin-1 beta action on insulin release, since a relative protection against interleukin-1 beta effects on acute insulin release was found at high (28 mmol/l) concentrations of D-glucose, and blocking nitrite production by the L-arginine analog aminoguanidine, which selectively inhibits the cytokine-inducible nitric oxide synthase, did not result in protection against the inhibitory action of interleukin-1 beta. Neither L-glucose nor the secretagogues L-leucine, tolbutamide and 3-isobutyl-1-methyl xanthine shared the potentiating effect of D-glucose. The phosphodiesterase inhibitor 3-isobutyl-l-methyl xanthine reduced interleukin-1 beta-induced nitrite production at 3.3 mmol/l D-glucose, an effect that could be reproduced by the cAMP analog dibutyryl cAMP. Addition of 3-isobutyl-l-methyl xanthine resulted in a threefold reduction in the mRNA level of interleukin-1 beta-induced inducible nitric oxide synthase. We conclude that interleukin-1 beta-induced islet nitric oxide synthesis is augmented by D-glucose, but not by non-substrate secretagogues, and that secretagogues that elevate cAMP inhibit islet nitric oxide production.
引用
收藏
页码:251 / 259
页数:9
相关论文
共 44 条
  • [21] L-ARGININE STIMULATES CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE FORMATION IN RAT ISLETS OF LANGERHANS AND RINM5F INSULINOMA CELLS - EVIDENCE FOR L-ARGININE-NITRIC OXIDE SYNTHASE
    LAYCHOCK, SG
    MODICA, ME
    CAVANAUGH, CT
    [J]. ENDOCRINOLOGY, 1991, 129 (06) : 3043 - 3052
  • [22] MANDRUPPOULSEN T, 1987, ACTA PATH MICRO IM C, V95, P55
  • [23] MANDRUPPOULSEN T, 1986, DIABETOLOGIA, V29, P63, DOI 10.1007/BF02427283
  • [24] ISLET CYTOTOXICITY OF INTERLEUKIN-1 - INFLUENCE OF CULTURE CONDITIONS AND ISLET DONOR CHARACTERISTICS
    MANDRUPPOULSEN, T
    SPINAS, GA
    PROWSE, SJ
    HANSEN, BS
    JORGENSEN, DW
    BENDTZEN, K
    NIELSEN, JH
    NERUP, J
    [J]. DIABETES, 1987, 36 (05) : 641 - 647
  • [25] MARLETTA MA, 1993, J BIOL CHEM, V268, P12231
  • [26] MESSMER UK, 1994, CELL SIGNAL, V6, P17
  • [27] COMPARISON OF BIOLOGICAL AND IMMUNOLOGICAL ACTIVITIES OF HUMAN MONOCYTE-DERIVED INTERLEUKIN-1-BETA AND HUMAN RECOMBINANT INTERLEUKIN-1-BETA
    MOLVIG, J
    HANSEN, BS
    WORSAAE, H
    HEJNAES, KR
    HELLE, M
    DALBOGE, H
    NERUP, J
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1990, 31 (02) : 225 - 235
  • [28] MONCADA S, 1991, PHARMACOL REV, V43, P109
  • [29] NERUP J, 1988, DIABETES CARE, V11, P16
  • [30] PANCREATIC B-CELLS POSSESS DEFENSE-MECHANISMS AGAINST CELL-SPECIFIC TOXICITY
    PIPELEERS, D
    VANDEWINKEL, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (14) : 5267 - 5271